tradingkey.logo
tradingkey.logo
Search

United Therapeutics Corp

UTHR
Add to Watchlist
500.350USD
-2.350-0.47%
Close 09-15 16:00ET
21.35BMarket Cap
17.09P/E TTM

United Therapeutics Corp (UTHR) Revenue Performance

Updated: Jun 30, 2026

Last year, United Therapeutics Corp generated 1.29B USD for its biggest-performing segment, Tyvaso DPI. The United States made the largest contribution, accounting for 3.04B USD last year. For the latest quarter, United Therapeutics Corp reported the revenue of 326.60M USD for the period ending 2026-06-30, which came from the top-performing segment, Tyvaso DPI. United States contributed the highest revenue, at 783.30M USD.

By Business

Annual
Annual
Quarterly
Tyvaso DPI
Nebulized Tyvaso
Remodulin
Orenitram
Unituxin
Adcirca
Other
Tyvaso
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Tyvaso DPI
1.29B(40.59%)
1.03B(35.92%)
731.10M(31.41%)
--(--)
--(--)
--(--)
--(--)
--(--)
Nebulized Tyvaso
585.70M(18.40%)
586.80M(20.39%)
502.60M(21.59%)
--(--)
--(--)
--(--)
--(--)
--(--)
Remodulin
526.80M(16.55%)
538.10M(18.70%)
494.80M(21.26%)
500.20M(25.83%)
513.70M(30.48%)
516.70M(34.83%)
587.00M(40.52%)
599.00M(36.80%)
Orenitram
496.90M(15.61%)
434.30M(15.09%)
359.40M(15.44%)
325.10M(16.79%)
306.10M(18.16%)
293.10M(19.76%)
225.30M(15.55%)
205.10M(12.60%)
Unituxin
226.80M(7.13%)
238.70M(8.30%)
198.90M(8.55%)
182.90M(9.45%)
202.30M(12.00%)
122.90M(8.29%)
113.70M(7.85%)
84.80M(5.21%)
Adcirca
30.00M(0.94%)
23.80M(0.83%)
28.90M(1.24%)
41.30M(2.13%)
55.90M(3.32%)
67.30M(4.54%)
107.20M(7.40%)
323.70M(19.89%)
Other
24.00M(0.75%)
22.10M(0.77%)
11.80M(0.51%)
13.80M(0.71%)
--(--)
--(--)
--(--)
--(--)
Tyvaso
700.00K(0.02%)
--(--)
--(--)
873.00M(45.09%)
607.50M(36.04%)
483.30M(32.58%)
415.60M(28.69%)
415.20M(25.51%)

By Region

Annual
Annual
Quarterly
United States
Rest of World
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
United States
3.04B(95.42%)
2.74B(95.21%)
2.20B(94.62%)
1.81B(93.69%)
1.56B(92.80%)
1.41B(95.20%)
1.32B(91.33%)
1.53B(93.88%)
1.54B(89.07%)
1.46B(91.44%)
1.35B(92.31%)
1.18B(91.64%)
1.03B(92.43%)
846.61M(92.42%)
676.97M(91.09%)
Rest of World
145.70M(4.58%)
137.70M(4.79%)
125.30M(5.38%)
122.20M(6.31%)
121.30M(7.20%)
71.20M(4.80%)
125.60M(8.67%)
99.60M(6.12%)
188.50M(10.93%)
136.90M(8.56%)
112.76M(7.69%)
107.76M(8.36%)
84.55M(7.57%)
69.47M(7.58%)
66.22M(8.91%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.